Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04485234 · ClinicalTrials.gov registry record
Inclusive Invasive Physiological Assessment in Angina Syndromes Registry
A clinical trial of Coronary Artery Disease and Microvascular Coronary Artery Disease, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).
- Completed
- Registry status
- 2,322
- Enrollment target
- 12
- Study locations
NCT04485234: Completed study of Coronary Artery Disease and Microvascular Coronary Artery Disease, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).
NCT04485234 is a study of Coronary Artery Disease and Microvascular Coronary Artery Disease that has completed, run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The registered enrollment target is 2,322 participants, above the 1,276-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (82% higher). The trial reports 12 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04485234, a study of Coronary Artery Disease and Microvascular Coronary Artery Disease, has completed, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).
- COMPLETED
- Registry status
- 2,322 participants
- Enrollment target
- 12
- Study locations
Study Summary
This study evaluates the prognostic value and potential therapeutic impact of combined pressure and flow measurements in the evaluation of epicardial coronary stenosis and microvascular function.
Primary Outcome
Cumulative incidence of a composite of any death, any myocardial infarction, or any ischemia-driven revascularization
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Resting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistance
Study Locations (12)
Other
- Aarhus University Hospital - Aarhus
- Catholic University of the Sacred Heart - Roma
- Gifu Heart Center - Gifu
- Toda Central General Hospital - Toda
- Tsuchiura Kyodo General Hospital - Tsuchiura
- Amsterdam UMC - location AMC - Amsterdam
- Tergooi - Blaricum
- Amphia Hospital - Breda
- Samsung Medical Center - Seoul
- Seoul National University Hospital - Seoul
- Hospital Clinico San Carlos - Madrid
Ohio
- Cincinnati University Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,322 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2021-03-25 |
What the finished NCT04485234 record still lists
NCT04485234 is an observational study that tracks outcomes without assigning an intervention. Its 2,322 participants enrollment target places it among the larger protocols in the corpus, above the 1,276-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (82% higher).
The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Resting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistance is the first listed.
NCT04485234 lists 12 locations in 2 states (Other, Ohio).
Frequently Asked Questions
What is clinical trial NCT04485234 about?
NCT04485234 is a clinical study titled "Inclusive Invasive Physiological Assessment in Angina Syndromes Registry". This study evaluates the prognostic value and potential therapeutic impact of combined pressure and flow measurements in the evaluation of epicardial coronary stenosis and microvascular function.
What is the current status of trial NCT04485234?
This trial is currently completed. The enrollment target is 2,322 participants. The study started on 2019-06-01. Estimated completion is 2021-03-25.
What conditions does trial NCT04485234 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Microvascular Coronary Artery Disease.
What interventions are being tested in trial NCT04485234?
The interventions under investigation include: Resting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistance (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04485234?
This trial is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04485234 being conducted?
This trial has 12 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04485234's enrollment target sits among peer trials
2,322 25th of 219 higher than 195 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
- NCT06824194 · 2,320 participants · Phase 3
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- NCT06679140 · 2,330 participants · Phase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- NCT05485961 · 2,310 participants · Phase 2
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI